홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Methyl iodide → 1,1-Dimethylethyl 1,3-dimethyl-2-oxo-4-imidazolidinecarboxylate

HRID 2081053
인쇄

반응식

HRID 2081053 반응식
[CH3:1][N:2]1[CH2:6][CH:5]([C:7]([O:9][C:10]([CH3:13])([CH3:12])[CH3:11])=[O:8])[NH:4][C:3]1=[O:14].O=[C:16]1N(C(OCC2C=CC=CC=2)=O)[C@H](C(O)=O)CN1.CI.[H-].[Na+]>CN(C)C=O>[CH3:1][N:2]1[CH2:6][CH:5]([C:7]([O:9][C:10]([CH3:11])([CH3:13])[CH3:12])=[O:8])[N:4]([CH3:16])[C:3]1=[O:14]
참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트

참가 물질

6

반응물 4

HCID 6328Methyl iodideHCID 24758Sodium hydrideHCID 688196(S)-(-)-2-Oxo-1,5-imidazolidinedicarboxylic acid 1-benzyl esterHCID 130539751,1-Dimethylethyl 1-methyl-2-oxo-4-imidazolidinecarboxylate

생성물 1

HCID 671036841,1-Dimethylethyl 1,3-dimethyl-2-oxo-4-imidazolidinecarboxylate수율 79%

시약·촉매·용매 1

HCID 6228Dimethylformamide용매

반응 조건

온도
-10 °C

실험 절차

A stirred solution of 1,1-dimethylethyl 1-methyl-2-oxo-4-imidazolidinecarboxylate (1.75 g, 8.74 mmol) (prepared as described in step (i) of Example 49 from 5-(1,1-dimethylethyl)1-(phenylmethyl)3-methyl-2-oxo-1,5-imidazolidinedicarboxylate, itself prepared as described in step (ii) of Example 13, starting originally from (4S)-2-oxo-3-{[(phenylmethyl)oxy]carbonyl}-4-imidazolidinecarboxylic acid) in N,N-dimethylformamide (22 ml) was cooled to −10° C. under argon, and then the methyl iodide (2.186 ml, 35.0 mmol) was added. Sodium hydride (60% dispersion in oil) (0.329 g, 8.22 mmol) was then added portion wise. The reaction mixture was allowed to warm to RT while stirring under argon overnight. The solvent was evaporated in vacuo and then the residue partitioned between ethyl acetate (40 ml) and brine (30 ml). The aqueous layer was re-extracted with ethyl acetate (×2) and then the combined organic extracts were washed with water (×2, 50 ml), brine (50 ml) and dried over magnesium sulphate. The solvent was evaporated in vacuo. The crude product was purified by flash-silica gel chromatography, eluting with 25-100% ethyl acetate/iso-hexane. The fractions containing product were combined and solvent evaporated in vacuo to give a yellow oil, 1,1-dimethylethyl 1,3-dimethyl-2-oxo-4-imidazolidinecarboxylate (1.48 g, 79% yield). (ii) A solution of 1,1-dimethylethyl 1,3-dimethyl-2-oxo-4-imidazolidinecarboxylate (1.92 g, 8.96 mmol) in dichloromethane (12 ml)/trifluoroacetic acid (6.00 ml) was stirred at room temperature for 24 hours. The solution was evaporated and the residue was co-evaporated with toluene (×3) and then dichloromethane (×2). The product was then dried to give crude 1,3-dimethyl-2-oxo-4-imidazolidinecarboxylic acid (1.65 g) which was dissolved in dichloromethane (90 ml) to give a ˜0.1M solution in dichloromethane which was used in subsequent reactions. LC/MS [M+H]+=159.

후처리

  1. customprepared
  2. temperatureto warm to RT
  3. customThe solvent was evaporated in vacuo
  4. customthe residue partitioned between ethyl acetate (40 ml) and brine (30 ml)
  5. extractionThe aqueous layer was re-extracted with ethyl acetate (×2)
  6. washthe combined organic extracts were washed with water (×2, 50 ml), brine (50 ml)
  7. dry with materialdried over magnesium sulphate
  8. customThe solvent was evaporated in vacuo
  9. customThe crude product was purified by flash-silica gel chromatography
  10. washeluting with 25-100% ethyl acetate/iso-hexane
  11. additionThe fractions containing product
  12. customsolvent evaporated in vacuo

출처 및 근거

ORD 기록
ord-4bc82e698e784113aabb6f2d81c6af15
출처 데이터셋
uspto-grants-2011_04
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07932282B2

반응 노트

이 페이지에서참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트